[Clinicopathologic significance of bcl-6 gene rearrangement and expression in three molecular subgroups of diffuse large B-cell lymphoma].
Fangping Xu(Guangdong Academy of Medical Sciences), Wenyu Li(Shenyang Agricultural University), Jie Xu(Wannan Medical College), Fen Zhang(Guangdong General Hospital), Yan‐Hui Liu(Hainan University), Donglan Luo(Guangdong General Hospital), Xin Du(Beijing Anzhen Hospital), Xin-lan Luo(Guangdong General Hospital), Heng-guo Zhuang, Li Li(Guangdong General Hospital), Minghui Zhang
PubMed
June 1, 2008
Cited by 2
Related Papers
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor Cells
|Clinical Cancer Research|2017|136
PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer
|International Journal of Oncology|2015|131
Catalytic Activity of Human ADAM33
|Journal of Biological Chemistry|2004|117
Overexpression of eIF5A‐2 is an adverse prognostic marker of survival in stage I non–small cell lung cancer patients
|International Journal of Cancer|2010|95